THE ULTIMATE GUIDE TO PICEATANNOL 4'-O-?-D-GLUCOPYRANOSIDE

These trials confirmed clinically significant pharmacokinetic interactions [seven] characterised by a decrease inside the clearance with the anticancer drug and for this reason increased publicity. The interpretation of subsequent period II and III scientific trials was complicated since it was not possible to administer exactly the same dose of ch